Scopolamine Market Size & Share, by Dosage Form (Tablet, Syrup, Injection, Patch); Distribution Channel (Hospital, Retail, Online Pharmacies) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3312
  • Published Date: Apr 12, 2023
  • Report Format: PDF, PPT

Companies Dominating the Scopolamine Landscape

    • Pfizer Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Baxter International Inc.
    • Myungmoon Pharm Co. Ltd
    • Alchem International Pvt. Ltd.
    • Caleb Pharmaceuticals, Inc.
    • GlaxoSmithKline plc
    • Aktivax, Inc.
    • Southwest Research Institute
    • Perrigo Company plc
    • Novartis International AG

Browse Key Market Insights with Data Illustration:


In The News

  •  Southwest Research Institute developed a fully synthetic method to produce scopolamine which is a plant-based medicine. This was developed to improve the drug availability which was disrupted by wildfires, climatic conditions, pests, crop diseases, and weather.

  • Aktivax, Inc. was awarded a USD 24.5 million US government project for developing a scopolamine autoinjector under a 5-year OT agreement with the approval of the U.S. Food and Drug Administration. The autoinjector was developed to treat the poisoning of organophosphate nerve agents in the military.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 3312
  • Published Date: Apr 12, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing number of surgical procedures, the number of people suffering from digestive disorders, and psychological disorders are the major factors driving the market growth.

The market size of scopolamine is anticipated to attain a CAGR of ~5% over the forecast period, i.e., 2023-2035.

Tough guidelines for assembling and selling, and occurrence of COVID-19, and the disruption of healthcare are estimated to be the growth-hindering factors for the market expansion.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Pfizer, Inc., Baxter International Inc., Myungmoon Pharm Co Ltd, Alchem International Pvt. Ltd., Caleb Pharmaceuticals, Inc., GlaxoSmithKline plc., Aktivax, Inc., Southwest Research Institute, Perrigo Company plc, Novartis International AG, among others.

The company profiles are selected on the basis of revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by dosage form, distribution channel, and by region.

The hospital pharmacies segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying